The Challenger Ltd (ASX: CGF) share price is in focus today after the company welcomed APRA's new capital framework for longevity products, due to start from July 2026. Challenger expects the move will lower required capital and reduce risk for lifetime income product providers.
Image source: Getty Images
What did Challenger report?
- APRA finalised changes to capital settings for longevity product providers, effective 1 July 2026
- Reforms expected to lower required capital and cyclical risk for Challenger
- Challenger to detail business impacts at Investor Day on 26 May 2026
- Challenger Life remains Australia's largest provider of annuities
What else do investors need to know?
Challenger has welcomed APRA's reforms, saying they represent the biggest changes for longevity product providers in a generation. The company believes these changes will help develop Australia's retirement income market as more Australians enter retirement each year.
Challenger operates both a fiduciary funds management division and an APRA-regulated Life division. The business remains firmly focused on providing customers with financial security in retirement.
What did Challenger management say?
Managing Director and Chief Executive Officer Nick Hamilton said:
We strongly welcome APRA's reforms, which represent the biggest changes for providers of longevity products in a generation. For Challenger, it will lower the levels of required capital and cyclical risks to our capital position during times of market stress, while maintaining policyholder security.
What's next for Challenger?
Challenger plans to work through the details of the new capital standards and will provide more information about their impact at its upcoming Investor Day in May 2026. The company continues to advocate for policy changes that support retirees' financial confidence and improve the sustainability of lifetime income products.
Investors can expect further updates as Challenger refines its approach in light of these regulatory changes, helping position the business for the future.
Challenger share price snapshot
Over the past 12 months, Challenger shares have risen 38%, outperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 8% over the same period.
